IAS–USA funding comes from a variety of sources. The largest single source of revenue is conference and CME participant registration fees.
Other funding sources include grants and subcontracts from government agencies, grants from the pharmaceutical/diagnostics (commercial) industries, private donations, and gifts-in-kind from local community businesses and individuals.
The commercial support that IAS–USA accepts is only for selected activities. IAS–USA is accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. Two large national CME efforts (one on HIV and another on HCV) invite funding in the form of educational grants from industry. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities within the effort at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speaker(s). Grantors are listed in each activity as applicable.
Commercial support enhances the educational benefits for our audience and improves health care for the public. To ensure establishment of relationships with industry entities without compromising accepted ethical and educational standards, the IAS–USA endorses and conforms to the following statements and opinions that have been issued on this subject:
- The ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities, Accreditation Council for Continuing Medical Education,
- The AMA CEJA Gifts to Physicians from Industry, American Medical Association Council on Ethical and Judicial Affairs,
- The PHARMA Code on Interaction with Healthcare Professionals, Pharmaceutical Research and Manufacturers of America,
- And importantly, the IAS–USA Program Development Policies.
By policy, certain IAS–USA activities, such as Guidelines, do not allow commercial support.
Program Development and Commercial Support
The first 3 above mentioned guidelines and statements alone may not ensure the complete independence of any CME activity funded in any part by industry. For this reason, IAS–USA has created additional, rigorous internal policies that govern any activity that may invite commercial support. These policies can be found here and essentially include:
- Any IAS–USA program that receives commercial support must have support from several companies with competing products. Absolutely no single-company commercial support is permitted for any IAS–USA activity
- These grants are pooled and used to support the specific national efforts as designated and controlled by the IAS–USA.
- Individuals who participate in marketing or promotional activities for commercial firms (eg, paid lectures for industry) may not participate in IAS–USA general educational and informational activities.
- Before medical professionals can create or present content for IAS–USA programs, they must disclose all relationships, financial or otherwise, with all commercial and other outside entities.
- The content and recommendations of all IAS–USA activities are subject to independent peer review.
- IAS–USA does not invite or accept any advertising revenue (eg, in any venue, including the journal and the website) or commercial exhibit revenue (eg, at CME courses or Conference on Retroviruses and Opportunistic Infections) nor participate in any product or company promotion.